文献速递流行病学与生物统计真实世界研究与卫生经济

国际移民死亡率的全球模式:系统综述与Meta分析

Global patterns of mortality in international migrants: a systematic review and meta-analysis.
PubMed 文献 · Lancet · 2018-12-05

BACKGROUND: 258 million people reside outside their country of birth; however, to date no global systematic reviews or meta-analyses of mortality data for these international migrants have been done.…

要点

  • 除传染病和外部原因外,所有13个ICD-10类别SMR均低于一般人群。

核心结论

  • 国际移民相对于目的地国家一般人群具有死亡率优势,且该优势在多数ICD-10疾病类别中持续存在。
  • 该优势主要代表在高收入国家学习、工作或家庭团聚的国际移民,可能不反映中低收入国家边缘化群体的健康结局。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、Embase、Cochrane Library和Google Scholar,时间范围为2001年1月1日至2017年3月31日,无语言限制。
  • 纳入报告任何年龄国际移民死亡率结局的观察性研究、系统综述和随机对照试验;排除仅从重症监护或高依赖病房招募、有现有健康状况或特定健康暴露、仅限孕产妇或围产期结局的研究。
  • 使用随机效应模型计算汇总估计;研究注册号PROSPERO CRD42017073608。

主要发现

  • 所有13个ICD-10类别的SMR均低于目的地国家一般人群,但传染病和外部原因除外。
  • 移民全因年龄标准化死亡率的点估计范围为每10万人420至874例。

关键数值与推荐

  • 移民全因年龄标准化死亡率点估计范围为每10万人420至874例。

临床怎么用

  • 在高收入国家,国际移民的死亡率总体低于一般人群,临床评估时应结合这一流行病学背景。
  • 难民显示出显著死亡率优势,而寻求庇护者未见优势,提示不同移民亚组的健康风险存在差异。
  • 传染病和外部原因是移民中SMR未显示优势的类别,应作为健康监测和干预的重点方向。

局限性

  • 数据主要来自高收入国家,中低收入国家数据极少,可能不反映边缘化群体的健康结局。
  • 难民、寻求庇护者和劳工移民的死亡率估计数据有限(分别为110、144和6个估计)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: 258 million people reside outside their country of birth; however, to date no global systematic reviews or meta-analyses of mortality data for these international migrants have been done. We aimed to review and synthesise available mortality data on international migrants. METHODS: In this systematic review and meta-analysis, we searched MEDLINE, Embase, the Cochrane Library, and Google Scholar databases for observational studies, systematic reviews, and randomised controlled trials published between Jan 1, 2001, and March 31, 2017, without language restrictions. We included studies reporting mortality outcomes for international migrants of any age residing outside their country of birth. Studies that recruited participants exclusively from intensive care or high dependency hospital units, with an existing health condition or status, or a particular health exposure were excluded. We also excluded studies limited to maternal or perinatal outcomes. We screened studies using systematic review software and extracted data from published reports. The main outcomes were all-cause and International Classification of Diseases, tenth revision (ICD-10) cause-specific standardised mortality ratios (SMRs) and absolute mortality rates. We calculated summary estimates using random-effects models. This study is registered with PROSPERO, number CRD42017073608. FINDINGS: Of the 12 480 articles identified by our search, 96 studies were eligible for inclusion. The studies were geographically diverse and included data from all global regions and for 92 countries. 5464 mortality estimates for more than 15·2 million migrants were included, of which 5327 (97%) were from high-income countries, 115 (2%) were from middle-income countries, and 22 (<1%) were from low-income countries. Few studies included mortality estimates for refugees (110 estimates), asylum seekers (144 estimates), or labour migrants (six estimates). The summary estimate of all-cause SMR for international migrants was lower than one when compared with the general population in destination countries (0·70 [95% CI 0·65-0·76]; I2=99·8%). All-cause SMR was lower in both male migrants (0·72 [0·63-0·81]; I2=99·8%) and female migrants (0·75 [0·67-0·84]; I2=99·8%) compared with the general population. A mortality advantage was evident for refugees (SMR 0·50 [0·46-0·54]; I2=89·8%), but not for asylum seekers (1·05 [0·89-1·24]; I2=54·4%), although limited data was available on these groups. SMRs for all causes of death were lower in migrants compared with the general populations in the destination country across all 13 ICD-10 categories analysed, with the exception of infectious diseases and external causes. Heterogeneity was high across the majority of analyses. Point estimates of all-cause age-standardised mortality in migrants ranged from 420 to 874 per 100 000 population. INTERPRETATION: Our study showed that international migrants have a mortality advantage compared with general populations, and that this advantage persisted across the majority of ICD-10 disease categories. The mortality advantage identified will be representative of international migrants in high-income countries who are studying, working, or have joined family members in these countries. However, our results might not reflect the health outcomes of more marginalised groups in low-income and middle-income countries because little data were available for these groups, highlighting an important gap in existing research. Our results present an opportunity to reframe the public discourse on international migration and health in high-income countries. FUNDING: Wellcome Trust, National Institute for Health Research, Medical Research Council, Alliance for Health Policy and Systems Research, Department for International Development, Fogarty International Center, Grand Challenges Canada, International Development Research Centre Canada, Inter-American Institute for Global Change Research, National Cancer Institute, National Heart, Lung and Blood Institute, National Institute of Mental Health, Swiss National Science Foundation, World Diabetes Foundation, UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, and European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group Research Funding for the ESCMID Study Group for Infections in Travellers and Migrants.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Aldridge RW, Nellums LB, Bartlett S, et al. Global patterns of mortality in international migrants: a systematic review and meta-analysis. Lancet. 2018. PMID: 30528484. doi:10.1016/S0140-6736(18)32781-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。